Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Lipid Suspension Enema for Left-sided/Distal Ulcerative Colitis
NCT06867042Phase 2Not yet recruiting
- Sponsor
- Jina Pharmaceuticals, Inc.
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 2 trial of tacrolimus in ulcerative colitis (UC), sponsored by Jina Pharmaceuticals, Inc.. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06867042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06867042.